Areas of Expertise and Treatments
Bone marrow transplantation uses healthy blood-forming stem cells to restore bone marrow function in selected malignant and non-malignant blood disorders.
Autologous transplantation uses the patient's own collected stem cells following intensive treatment and may be considered for selected haematological malignancies.
Allogeneic transplantation uses stem cells from a compatible donor and may be used for selected leukemias, lymphomas and other serious blood disorders.
Haploidentical transplantation uses stem cells from a partially matched family donor when an appropriate fully matched donor is unavailable.
Leukemia treatment may include chemotherapy, targeted therapies, supportive care and stem cell transplantation depending on the disease subtype and risk profile.
Lymphoma treatment is selected according to lymphoma type and stage and may include systemic therapy and stem cell transplantation in selected patients.
Multiple myeloma treatment may involve combination systemic therapy and autologous stem cell transplantation in suitable patients.
Bone marrow aspiration and biopsy help diagnose and monitor blood disorders by examining blood-forming tissue from the bone marrow.
Intrathecal chemotherapy delivers anticancer medicines into the fluid surrounding the brain and spinal cord for selected haematological malignancies.
Thrombophilia management focuses on identifying and treating conditions that increase the tendency to develop abnormal blood clots.
Management of platelet and coagulation disorders focuses on diagnosing and treating abnormal bleeding or clotting conditions.
Sickle cell crisis management includes supportive treatment, transfusion when required and management of acute complications.